Search

Your search keyword '"Grimaud J.-C."' showing total 270 results
Start Over Author "Grimaud J.-C."
270 results on '"Grimaud J.-C."'

13. Conseils pour la pratique de l’Endoscopie Œso-Gastro-Duodńale (EOGD) de qualité: Comité d’évaluation technologique de la Société Française d’Endoscopie Digestive (SFED)

Author

Canard, J. M., Palazzo, L., Fontaine, H., Boyer, J., Dalbies, P., Dumas, R., Escourrou, J., Florent, C., Gay, G., Greff, M., Grimaud, J. C., Helbert, T., Lapuelle, J., Letard, J. C., Marchetti, B., Napoleon, B., Ponchon, T., Rey, J. F., Sautereau, D., Systchenko, R., and Vallot, T.

Published
2003
Full Text
View/download PDF

21. Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease : long-term data from CALM

Author

Yzet, C., Ungaro, R., Bossuyt, P., Baert, F., Vanasek, T., D'Haens, G., Joustra, V., Panaccione, R., Novacek, G., Armuzzi, A., Golovchenko, O., Prymak, O., Goldis, A., Travis, S., Hebuterne, X., Ferrante, M., Rogler, G., Fumery, M., Danese, S., Rydzewska, G., Pariente, B., Hertervig, E., Stanciu, C., Grimaud, J. -C, Diculescu, M. -M, Peyrin-Biroulet, L., Laharie, D., Wright, J. P., Gomollon, F., Gubonina, I., Schreiber, S., Motoya, S., Hellström, P., Halfvarson, Jonas, Colombel, J. -F, Yzet, C., Ungaro, R., Bossuyt, P., Baert, F., Vanasek, T., D'Haens, G., Joustra, V., Panaccione, R., Novacek, G., Armuzzi, A., Golovchenko, O., Prymak, O., Goldis, A., Travis, S., Hebuterne, X., Ferrante, M., Rogler, G., Fumery, M., Danese, S., Rydzewska, G., Pariente, B., Hertervig, E., Stanciu, C., Grimaud, J. -C, Diculescu, M. -M, Peyrin-Biroulet, L., Laharie, D., Wright, J. P., Gomollon, F., Gubonina, I., Schreiber, S., Motoya, S., Hellström, P., Halfvarson, Jonas, and Colombel, J. -F

Published
2019
Full Text
View/download PDF

23. Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study

Author

Portal, I., Bourlière, M., Halfon, P., De Lédinghen, V., Couzigou, P., Bernard, P. H., Blanc, F., Caroli-Bosc, F., Arpurt, J. P., Vetter, D., Mathieu-Chandelier, C., Chazouillères, O., Thiefin, G., Pol, S., Sogni, P., Abergel, A., Bailly, F., Picon, M., Debonne, J. M., Zamora, C., Alleman, I., Moreau, X., Doll, F., Eugène, C., Ducloux, S., Larrey, D., Ouzan, D., Grimaud, J. C., Gouvernet, J., Botti, G., Gérolami, V., Khiri, H., Gérolami, A., Gauthier, A. P., and Botta-Fridlund, D.

Published
2003

27. OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn’s disease: long-term data from CALM

Author

Yzet, C, primary, Ungaro, R, additional, Bossuyt, P, additional, Baert, F, additional, Vanasek, T, additional, D’Haens, G, additional, Joustra, V, additional, Panaccione, R, additional, Novacek, G, additional, Armuzzi, A, additional, Golovchenko, O, additional, Prymak, O, additional, Goldis, A, additional, Travis, S, additional, Hébuterne, X, additional, Ferrante, M, additional, Rogler, G, additional, Fumery, M, additional, Danese, S, additional, Rydzewska, G, additional, Pariente, B, additional, Hertervig, E, additional, Stanciu, C, additional, Grimaud, J-C, additional, Diculescu, M-M, additional, Peyrin-Biroulet, L, additional, Laharie, D, additional, Wright, J P, additional, Gomollón, F, additional, Gubonina, I, additional, Schreiber, S, additional, Motoya, S, additional, Hellström, P, additional, Halfvarson, J, additional, and Colombel, J-F, additional

Published
2019
Full Text
View/download PDF

28. P286 Bariatric surgery in inflammatory bowel disease: outcome and safety from a GETAID registry population

Author

Reenaers, C, primary, Nachury, M, additional, Stefanescu, C, additional, Pineton de Chambrun, G, additional, Laharie, D, additional, Boileve, J, additional, Viennot, S, additional, Peyrin-Biroulet, L, additional, Roblin, X, additional, Grimaud, J-C, additional, Bouguen, G, additional, Nahon, S, additional, Goutorbe, F, additional, and Coffin, B, additional

Published
2019
Full Text
View/download PDF

31. Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE].

Author

Moreau, J, Hammoudi, N, Marthey, L, Trang-Poisson, C, Nachury, M, Altwegg, R, Grimaud, J C, Orempuller, S, Hébuterne, X, Aubourg, A, Baudry, C, Seksik, P, Roblin, X, Nahon, S, Savoye, G, Mesnard, B, Stefanescu, C, Simon, M, Coffin, B, and Fumery, M

Abstract

Background Better patient knowledge on inflammatory bowel disease [IBD] could improve outcome and quality of life. The aim of this study was to assess if an education programme improves IBD patients' skills as regards their disease. Methods The GETAID group conducted a prospective multicentre randomised controlled study. IBD patients were included at diagnosis, or after a significant event in the disease course. Patients were randomised between 'educated' or control groups for 6 months. Education was performed by trained health care professionals. A psycho-pedagogic score [ECIPE] was evaluated by a 'blinded' physician at baseline and after 6 and 12 months [M6 and M12]. The primary endpoint was the increase of ECIPE score at M6 of more than 20%. Results A total of 263 patients were included in 19 centres (male:40%; median age:30.8; Crohn's disease [CD]:73%). Of these, 133 patients were randomised into the educated group and 130 into the control group. The median relative increase in ECIPE score at M6 was higher in the educated group as compared with the control group (16.7% [0–42.1%] vs 7% [0–18.8%], respectively, p = 0.0008). The primary endpoint was met in 46% vs 24% of the patients in the educated and control groups, respectively [ p = 0.0003]. A total of 92 patients met the primary endpoint. In multivariate analysis, predictors of an increase of at least 20% of the ECIPE score were randomisation in the educated group (odds ratio [OR] = 2.59) and no previous surgery [OR = 1.92]. Conclusions These findings support the set-up of education programmes in centres involved in the management of IBD patients. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

32. P593 Efficacy, tolerance and safety of low-volume bowel preparations in inflammatory bowel diseases: Results from a French national multicentre study

Author

Briot, C, primary, Faure, P, additional, Parmentier, A L, additional, Gay, C, additional, Trang, C, additional, Nachury, M, additional, Viennot, S, additional, Altwegg, R, additional, Bulois, P, additional, Thomassin, L, additional, Serrero, M, additional, Ah Soune, P, additional, Gilletta, C, additional, Plastaras, L, additional, Simon, M, additional, Dray, X, additional, Caillo, L, additional, Del Tedeco, E, additional, Abitbol, V, additional, Zallot, C, additional, Degand, T, additional, Rossi, V, additional, Bonnaud, G, additional, Colin, D, additional, Morel, B, additional, Danset, J B, additional, Winkfield, B, additional, Filippi, J, additional, Amiot, A, additional, Attar, A, additional, Bourreille, A, additional, Grimaud, J C, additional, Blain, A, additional, Peyrin Biroulet, L, additional, and Vuitton, L, additional

Published
2018
Full Text
View/download PDF

33. Oesophageal and anorectal involvement in systemic sclerosis: a ă systematic assessment high resolution manometry

Author

Luciano, L., Granel, B., Bernie, E., Harle, J. -R., Baumstarck, K., Grimaud, J. -C., Bouvier, M., Vitton, V., Santé Publique et maladies Chroniques : Qualité de vie Concepts, Usages et Limites, Déterminants (SPMC), Assistance Publique - Hôpitaux de Marseille (APHM)-Aix Marseille Université (AMU), Service De Gastroenterologie, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, and Auquier, Pascal

Subjects
[SHS.PSY] Humanities and Social Sciences/Psychology, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, quality, [SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, [SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, [SHS.PSY]Humanities and Social Sciences/Psychology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SHS.ECO] Humanities and Social Sciences/Economics and Finance, [SHS.ECO]Humanities and Social Sciences/Economics and Finance
Abstract

International audience; Objective. In systemic sclerosis (SSc), oesophageal and anorectal ă involvements are frequent and often associated with each other. In ă clinical practice, oesophageal explorations are often prescribed, while ă anorectal explorations are rarely proposed and therefore, ă under-recognised. However, it is well documented in the literature that ă early detection of anorectal dysfunction could delay and/or prevent the ă onset of symptoms such as fecal incontinence (FI). The main objective ă was the systematic evaluation and detection of oesophageal and anorectal ă involvements in SSc patients. ă Methods. In this monocentric retrospective study, all patients with SSc ă addressed in the Department of Functional Digestive Explorations, North ă Hospital, Marseille for oesophageal and anorectal explorations were ă included. Self-Questionnaires, evaluating the symptoms and quality of ă life, were filled by patients during their visit. Explorations were ă performed on the same day: high resolution oesophageal manometry (EHRM), ă 3 Dimensional high resolution anorectal manometry (3DHRARM) and endo ă anal sonography (EUS). ă Results. 44 patients (41 women), mean age 59.8 +/- 12 years, were ă included. With regard to the symptoms, 45.5% of patients had ă gastro-oesophageal reflux disease (GERD), 66.9% dysphagia, 65.9% ă constipation and 773% Fl. The incidence of oesophageal dismotility was ă 65.9%, anorectal and both upper and lower dysfunction were 43.2%. More ă than 89% patients with abnormal explorations (EHRM, 3DHRARM or both) ă were symptomatic. Duration of SSc and altered quality of life was ă correlated with the severity of digestive involvement. ă Conclusion. Anorectal dysfunction appears to be closely linked to ă oesophageal involvement in SSc. Their routine screening is undoubtedly ă essential to limit the occurrence of severe symptoms such as FI.

Published
2016

34. Autoimmune pancreatitis associated with inflammatory bowel disease: a multicentric study of the GETAID

Author

Lorenzo, D., Maire, F., Stefanescu, C., Gornet, J. M., Seksik, P., Grimaud, J. C., Bournet, B., Marteau, P., Amiot, Audrey, Laharie, D., Trang, C., Coffin, B., Bellaiche, G., Cadiot, G., Reenaers, C., Racine, A., Viennot, S., Pauwels, A., Bouguen, G., Savoye, G., Pelletier, A. L., de Pineton Chambrun, G., Lahmek, P., Nahon, S., Abitbol, V, Service de gastroentérologie, MICI et assistance nutritive, pôle des maladies de l’appareil digestif, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Géoazur (GEOAZUR 6526), Institut de Recherche pour le Développement (IRD)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut national des sciences de l'Univers (INSU - CNRS)-Observatoire de la Côte d'Azur, COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA)-Centre National de la Recherche Scientifique (CNRS), Hôpital Robert Debré, Service d'Hépato-gastroentérologie, 51092 Reims, France, affiliation inconnue, Foie, métabolismes et cancer, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Pontchaillou [Rennes], CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), ONERA - The French Aerospace Lab [Palaiseau], ONERA-Université Paris Saclay (COmUE), Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de Recherche pour le Développement (IRD)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Nice Sophia Antipolis (... - 2019) (UNS), Université Côte d'Azur (UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-Centre National de la Recherche Scientifique (CNRS), Université de Rennes 1 (UR1), and Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )

Subjects
[SDV]Life Sciences [q-bio], ComputingMilieux_MISCELLANEOUS
Abstract

International audience; Meeting Abstract: P256

Published
2016

35. The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study

Author

Amiot, A., Grimaud, J. C., Treton, X., Filippi, J., Benjamin Pariente, Peyrin-Biroulet, L., Noureille, A., Buisson, A., Carbonnel, F., Bourrier, A., Nancey, S., Roblin, X., Marteau, P., Altwegg, R., Moreau, J., Aubourg, A., Savoye, G., Pelletier, A. L., Fumery, M., Bonaz, B., Bouhnik, Y., DESSAIVRE, Louise, Service de gastro-entérologie [Henri Mondor AP-HP, Créteil], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor, Service de Gastro-entérologie [CHU Hôpital Nord - Marseille], Hôpital Nord [CHU - APHM]-Assistance publique Hôpitaux de Marseille (APHM), Service de Gastroentérologie [Hôpital Beaujon], Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Archet 2 [Nice] (CHU), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service d'Hépato-gastro-entérologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Hôtel-Dieu de Nantes, Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), Institut National de la Recherche Agronomique (INRA)-Université d'Auvergne - Clermont-Ferrand I (UdA), Service d'Hépatologie Gastro-entérologie [CHU Clermont-Ferrand], CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Service d'Hépato-gastro-entérologie [APHP Kremlin-Bicêtre], AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Service de Gastro-entérologie et Hépatologie [CHU Saint-Etienne], Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Département d'Hépato-Gastroentérologie et de Transplantation Hépatique [CHU Saint-Eloi], Hôpital Saint Eloi (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Université de Montpellier (UM), Pôle Maladies de l'appareil digestif [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Département d'hépato-gastro-entérologie [Hôpital Trousseau : CHRU Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Service d'Hépato-Gastroentérologie [CHU Rouen], Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Service d'Hépato Gastroenterologie [CHU Amiens-Picardie], CHU Amiens-Picardie, CHU Grenoble, and European Crohn’s and Colitis Organisation

Subjects
[SDV] Life Sciences [q-bio], [SDV]Life Sciences [q-bio], [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Abstract

International audience

Published
2016

40. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Author

Regueiro, Miguel, primary, Feagan, Brian G., additional, Zou, Bin, additional, Johanns, Jewel, additional, Blank, Marion A., additional, Chevrier, Marc, additional, Plevy, Scott, additional, Popp, John, additional, Cornillie, Freddy J., additional, Lukas, Milan, additional, Danese, Silvio, additional, Gionchetti, Paolo, additional, Hanauer, Stephen B., additional, Reinisch, Walter, additional, Sandborn, William J., additional, Sorrentino, Dario, additional, Rutgeerts, Paul, additional, Debinski, H., additional, Florin, T., additional, Hetzel, D., additional, Lawrance, I., additional, Radford-Smith, G., additional, Sloss, A., additional, Sorrentino, D., additional, Gassner, S., additional, Haas, T., additional, Reicht, G., additional, Reinisch, W., additional, Strasser, M., additional, Vogelsang, H., additional, Bossuyt, P., additional, DeWit, O., additional, D'Haens, G., additional, Franchimont, D., additional, Louis, E., additional, Vermeire, S., additional, Bernstein, C.N., additional, Bourdages, R., additional, Chiba, N., additional, Dhalla, S.S., additional, Feagan, B.G., additional, Fedorak, R.N., additional, Lachance, J.R., additional, Panaccione, R., additional, Ropeleski, M., additional, Singh Salh, B., additional, Lukas, M, additional, Colombel, J-F, additional, Allez, M., additional, Desreumaux, P., additional, Dupas, J.L., additional, Grimaud, J-C., additional, Hebuterne, X., additional, Laharie, D., additional, Lerebours, E., additional, Peyrin-Biroulet, L., additional, Reimund, J-M., additional, Viennot, S., additional, Zerbib, F., additional, Antoni, C., additional, Atreya, R., additional, Baumgart, D.C., additional, Berg, C., additional, Boecker, U., additional, Bramkamp, G., additional, Bünning, C., additional, Ehehalt, R., additional, Howaldt, S., additional, Kucharzik, T., additional, Lamprecht, H.G., additional, Mudter, J., additional, Preiss, J.C., additional, Schreiber, S., additional, Seidler, U., additional, Altorjay, I., additional, Banai, J., additional, Lakatos, P.L., additional, Varga, M., additional, Vincze, A., additional, Avni-Biron, I., additional, Fishman, S., additional, Fraser, G.M., additional, Goldin, E., additional, Rachmilewitz, D., additional, Annese, V., additional, Ardizzone, S., additional, Biancone, L., additional, Bossa, F., additional, Danese, S., additional, Fries, W., additional, Gionchetti, P., additional, Maconi, G., additional, Terrosu, G., additional, Usai, P., additional, D'Haens, G.R., additional, Gearry, R.B., additional, Hill, J., additional, Rowbotham, D.S., additional, Schultz, M., additional, Stubbs, R.S., additional, Wallace, D., additional, Walmsley, R.S., additional, Wyeth, J., additional, Malecka-Panas, E., additional, Paradowski, L., additional, Regula, J., additional, Beales, I.P., additional, Campbell, S., additional, Hawthorne, A.B., additional, Parkes, M., additional, Travis, S.P., additional, Achkar, J.P., additional, Behm, B.W., additional, Bickston, S.J., additional, Brown, K.J., additional, Chiorean, M.V., additional, DeVilliers, W.J.S., additional, Elliott, D.E., additional, Grunkmeier, D., additional, Hamilton, J.W., additional, Hanauer, S.B., additional, Hanson, J.S., additional, Hardi, R., additional, Helper, D.J., additional, Herfarth, H., additional, Higgins, P.D.R., additional, Holderman, W.H., additional, Kottoor, R., additional, Kreines, M.D., additional, Leman, B.I., additional, Li, X., additional, Loftus, E.V., additional, Noar, M., additional, Oikonomou, I., additional, Onken, J., additional, Peterson, K.A., additional, Phillips, R.P., additional, Randall, C.W., additional, Ricci, M., additional, Ritter, T., additional, Rubin, D.T., additional, Safdi, M., additional, Sandborn, W.J., additional, Sauberman, L., additional, Scherl, E., additional, Schwarz, R.P., additional, Sedghi, S., additional, Shafran, I., additional, Sninsky, C.A., additional, Stein, I., additional, Swoger, J., additional, Vecchio, J., additional, Weinberg, D.I., additional, Wruble, L.D., additional, Yajnik, V., additional, and Younes, Z., additional

Published
2016
Full Text
View/download PDF

41. [Endoscopic management of postoperative pancreatic collections]

Author

Subtil, C., Moutardier, V., Vitton, V., Gasmi, M., Desjeux, A., Grimaud, J.-C., Berdah, S., Barthet, M., C, Brunet, Centre de recherche en neurobiologie - neurophysiologie de Marseille (CRN2M), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Image et ville (IV), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche et d'Application en Traitement de l'Image et du Signal (CREATIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-École Supérieure de Chimie Physique Électronique de Lyon (CPE)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-École Supérieure Chimie Physique Électronique de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), and Dumonceaud, Corinne

Subjects
Adult, Male, Adenocarcinoma, MESH: Splenectomy, MESH: Exudates and Transudates, MESH: Drainage, Endosonography, MESH: Pancreatic Cyst, Pancreatectomy, Postoperative Complications, MESH: Endoscopy, Digestive System, MESH: Pancreatectomy, MESH: Postoperative Complications, Cystadenoma, Mucinous, Pancreatic Pseudocyst, Humans, Endoscopy, Digestive System, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM], [SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM], MESH: Pancreatic Pseudocyst, Aged, MESH: Aged, Cholangiopancreatography, Endoscopic Retrograde, MESH: Humans, MESH: Middle Aged, MESH: Endosonography, MESH: Adenocarcinoma, MESH: Adult, Exudates and Transudates, Middle Aged, MESH: Male, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM], MESH: Cystadenoma, Mucinous, Pancreatic Neoplasms, Splenectomy, Drainage, MESH: Cholangiopancreatography, Endoscopic Retrograde, Female, MESH: Pancreatic Neoplasms, Pancreatic Cyst, MESH: Tomography, X-Ray Computed, Tomography, X-Ray Computed, MESH: Female
Abstract

International audience; INTRODUCTION: Treatment of pancreatic postoperative collections are usually managed with a multidisciplinary team. Different managements are possible: abstention, external drainage, endoscopic treatment or surgery. METHODS: We report on a case series of five patients with a postoperative pancreatic collection, endoscopically managed. Patients underwent all a CT scan associated or not with endoscopic ultrasonography. RESULTS: An endoscopic cystenterosotomy was performed in all the cases, with two double pig tail stents sometimes associated with nasocystic drainage for clearing the cyst lumen and with transpapillary drainage in one case. All the procedures were successful and patients healed in all the cases with the disappearance of the radiological image within a 33 days to three months range with one complication due to superinfection of the drained cyst, endoscopically managed with a nasocystic catheter. CONCLUSION: Therapeutic endoscopy, with a multidisciplinary approach, is a promising way to manage postoperative pancreatic collections.

Published
2008

42. [Ectopic pancreas: an exceptional cause of lower intestinal bleeding with hemorrhagic shock]

Author

Ah-Soune, P., Vitton, V., Subtil, C., Meunier-Carpentier, S., Bonmardion, R., Desjeux, A., Barthet, M., Grimaud, J.-C., Centre de recherche en neurobiologie - neurophysiologie de Marseille (CRN2M), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche et d'Application en Traitement de l'Image et du Signal (CREATIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-École Supérieure Chimie Physique Électronique de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Lyon-Université de Lyon-École Supérieure de Chimie Physique Électronique de Lyon (CPE)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), and Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

Subjects
MESH: Humans, MESH: Melena, MESH: Jejunal Diseases, MESH: Adult, MESH: Choristoma, MESH: Pancreas, MESH: Laparotomy, MESH: Male, MESH: Capsule Endoscopy, MESH: Shock, MESH: Colonoscopy, MESH: Rectum, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM], MESH: Gastrointestinal Hemorrhage, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2008

44. Rectal intussusception: can high resolution three-dimensional ano-rectal manometry compete with conventional defecography?

Author

Benezech, A., Cappiello, M., Baumstarck, K., Grimaud, J.‐C., Bouvier, M., and Vitton, V.

Subjects
HIGH resolution imaging, DEFECOGRAPHY, TOPOGRAPHIC maps, PELVIC floor, GOLD standard
Abstract

Background Three-dimensional high-resolution anorectal manometry (3 DHRAM), used for exploring anorectal disorders, was recently developed, providing interesting topographic data for the diagnosis of pelvic floor disorders such as excessive perineal descent. The aim of our study was to define a diagnostic strategy based on selected 3 DHRAM parameters to identify rectal intussusceptions ( RI), considering conventional defecography ( CD) as the gold standard. Methods All patients referred to our center in the previous 6 months for 3 DHRAM to explore fecal incontinence or constipation, and who previously achieved CD, were eligible. 3 DHRAM results were obtained for all classical parameters and the presence of a narrow band of high pressure in the anal canal during attempted defecation, which was recently found to be associated with RI in some studies. The sensitivity, specificity, and positive and negative predictive values were calculated for various 3 DHRAM criterion in order to propose a diagnostic strategy for RI. Key Results Twenty-six patients (66%) presented with RI on CD. On 3 DHRAM, according to our diagnostic strategy, the most relevant manometric criterion for the diagnosis of RI was the association of an anterior additional high-pressure area and an excessive perineal descent, with a positive predictive value of 100% [81.5-100], a specificity of 100% [75.3-100] and a sensibility of 69.2% [48.2-85.7]. Conclusions & Inferences In this study, 3 DHRAM was used to diagnose RI, and we confirmed its use in the diagnosis of pelvic floor disorders. Further studies will be necessary to define classifications for these new anatomic data from 3 DHRAM. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

46. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women : a double-blind, randomized, controlled study

Author

Marteau, P., Cuillerier, E., Meance, S., Gerhardt, M. F., Myara, A., Bouvier, M., Bouley, C., Tondu, F., Bommelaer, G., Grimaud, J. C., and DANONE, Admin

Subjects
[SDV.MP.PRB.BIF] Life Sciences [q-bio]/Microbiology and Parasitology/domain_sdv.mp.prb/domain_sdv.mp.prb.bif, fluids and secretions, digestive, oral, and skin physiology
Abstract

BACKGROUND: A previous study has suggested that Bifidobacterium animalis DN-173 010 shortens the colonic transit time in women. AIM: To confirm this effect and to determine whether modifications of the faecal bacterial mass and/or faecal secondary bile salts may be the explanation. METHODS: A double-blind, cross-over study was performed. Thirty-six healthy women were studied in four consecutive 10-day periods. During periods 2 and 4, they ingested three 125 g cups per day of a fermented milk which was either a product containing B. animalis DN-173 010 or a control without bifidobacteria. Periods 1 and 3 were run-in and washout periods, respectively. The total and segmental colonic transit times were assessed using a pellet method. In 12 subjects, all stools were collected and analysed for pH, faecal weight, bacterial mass and bile acids. RESULTS: The total and sigmoid transit times were significantly shorter during dosing with B. animalis compared to the control period. The other transit times, faecal weight, pH, bacterial mass and bile acids were not significantly affected. CONCLUSIONS: B. animalis DN-173 010 shortens the colonic transit time in healthy women. This effect is not explained by modifications of the faecal bacterial mass or secondary bile acids.

Published
2002

Catalog

Books, media, physical & digital resources
See catalog results